002349 精华制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资38,832-0.07%38,86140,117077,531
投资性房地产252,615-1.77%257,169266,2785364
固定资产569,815-3.75%592,010644,9991,103,761936,876
在建工程67,908-2.18%69,42361,51259,355273,693
无形资产61,455-1.71%62,52565,064123,239123,173
商誉167,9440.00%167,944167,944167,944167,944
其他非流动资产9,285-17.61%11,26966,962148,679156,096
1,167,854-2.61%1,199,2021,312,8761,603,0311,735,377

流动资产
货币资金995,0467.95%921,759933,267651,593581,319
应收账款311,59925.21%248,865219,069213,685235,441
存货294,3201.16%290,941307,653323,123307,779
其他流动资产416,183-20.61%524,244269,053406,664296,112
2,017,1481.58%1,985,8091,729,0431,595,0661,420,651

流动负债
短期借款25,91823.86%20,92521,02668,78276,568
应付票据185-98.63%13,48816,57935,43912,790
应付帐款135,6855.63%128,456123,027177,620167,819
其他流动负债139,887-29.58%198,641233,999321,397271,307
301,675-16.55%361,510394,631603,237528,484
流动资产净值1,715,4745.61%1,624,3001,334,412991,828892,166
资产总额减流动负债2,883,3282.12%2,823,5022,647,2882,594,8592,627,543

非流动负债
长期借款0--000120,000
应付债券0--0000
其他非流动负债17,935-6.77%19,23723,59225,30320,805
17,935-6.77%19,23723,59225,303140,805

总权益
    实收股本814,1810.00%814,181814,181835,724835,724
    储备项目1,692,4563.81%1,630,4121,586,7491,400,1141,271,780
股东权益2,506,6372.54%2,444,5932,400,9302,235,8392,107,505
非控股权益358,755-0.25%359,672222,767333,718379,234